Sotani Yasuyuki, Imai Hisanori, Kishi Maya, Yamada Hiroko, Matsumiya Wataru, Miki Akiko, Kusuhara Sentaro, Nakamura Makoto
Department of Surgery Division of Ophthalmology Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Ophthalmology Kansai Medical University, Hirakata, Japan.
Case Rep Ophthalmol Med. 2024 Aug 13;2024:2774155. doi: 10.1155/2024/2774155. eCollection 2024.
Valsalva retinopathy can cause submacular hemorrhage (SMH), which may lead to visual disturbances. SMH can extend into the subinternal limiting membrane (ILM) and vitreous spaces, sometimes occurring concomitantly with full-thickness macular holes (FTMHs). Herein, we describe a case in which sub-ILM hemorrhage was removed without peeling the ILM of the central fovea, thus preserving the foveal ILM. A 48-year-old female patient developed rapid-onset bilateral visual impairment due to SMH secondary to Valsalva retinopathy. The SMH predominantly consisted of sub-ILM hemorrhage. However, detailed observation was challenging due to the dense sub-ILM hemorrhage in the left eye. Initial best-corrected visual acuity (BCVA) in the right and left eyes were 1.2 and 0.03, respectively. Intravitreal tissue plasminogen activator (tPA) and sulfur hexafluoride (SF6) gas injections were initially administered to displace the SMH in the left eye; however, the SMH could not be successfully displaced. A vitrectomy was then performed. Intraoperatively, an ILM fissure beyond the foveal region was created using ILM forceps. The balanced salt solution was sprayed onto the ILM, and the sub-ILM hemorrhage was drained into the vitreous cavity from the ILM fissure. The surgery successfully displaced the sub-ILM hemorrhage while preserving the foveal ILM. No postoperative complications were observed. Visual acuity remained at 1.2 in the right eye and improved to 1.2 in the left eye 6 months postoperatively. Removing foveal sub-ILM hemorrhage without peeling the foveal ILM can be a viable treatment option to preserve the foveal ILM.
瓦尔萨尔瓦视网膜病变可导致黄斑下出血(SMH),这可能会引起视力障碍。SMH可延伸至内界膜(ILM)下和玻璃体腔,有时会与全层黄斑裂孔(FTMH)同时发生。在此,我们描述了一例在未剥除中央凹ILM的情况下清除ILM下出血,从而保留了中央凹ILM的病例。一名48岁女性患者因瓦尔萨尔瓦视网膜病变继发SMH而出现快速进展的双侧视力损害。SMH主要由ILM下出血组成。然而,由于左眼ILM下出血密集,详细观察具有挑战性。右眼和左眼的初始最佳矫正视力(BCVA)分别为1.2和0.03。最初向左眼玻璃体内注射组织型纤溶酶原激活剂(tPA)和六氟化硫(SF6)气体以置换SMH;然而,SMH未能成功置换。随后进行了玻璃体切除术。术中,使用ILM镊在中央凹区域以外制造一个ILM裂孔。将平衡盐溶液喷洒在ILM上,ILM下出血从ILM裂孔引流到玻璃体腔。手术成功置换了ILM下出血,同时保留了中央凹ILM。未观察到术后并发症。右眼视力维持在1.2,左眼术后6个月视力提高到1.2。在不剥除中央凹ILM的情况下清除中央凹ILM下出血可能是一种保留中央凹ILM的可行治疗选择。